Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1603-1609
Published online before print May 26, 2005, doi: 10.1161/01.ATV.0000171994.89106.ca
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/8/1603    most recent
01.ATV.0000171994.89106.cav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiekofer, S.
Right arrow Articles by Walsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiekofer, S.
Right arrow Articles by Walsh, K.
Related Collections
Right arrow Obesity
Right arrow Type 2 diabetes
Right arrow Angiogenesis
Right arrow Gene expression
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1603.)
© 2005 American Heart Association, Inc.


Vascular Biology

Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network

Stephan Schiekofer; Gennaro Galasso; Kaori Sato; Benjamin J. Kraus; Kenneth Walsh

From the Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts.

Correspondence to Dr Kenneth Walsh, PhD, Molecular Cardiology/Whitaker Cardiovascular Institute Boston University School of Medicine, 715 Albany St, W611 Boston, MA 02118. E-mail kxwalsh{at}bu.edu

Objective— Diabetes is a risk factor for the development of cardiovascular diseases associated with impaired angiogenesis or increased endothelial cell apoptosis.

Methods and Results— Here it is shown that angiogenic repair of ischemic hindlimbs was impaired in Leprdb/db mice, a leptin receptor–deficient model of diabetes, compared with wild-type (WT) C57BL/6 mice, as evaluated by laser Doppler flow and capillary density analyses. To identify molecular targets associated with this disease process, hindlimb cDNA expression profiles were created from adductor muscle of Leprdb/db and WT mice before and after hindlimb ischemia using Affymetrix GeneChip Mouse Expression Set microarrays. The expression patterns of numerous angiogenesis-related proteins were altered in Leprdb/db versus WT mice after ischemic injury. These transcripts included neuropilin-1, vascular endothelial growth factor-A, placental growth factor, elastin, and matrix metalloproteinases implicated in blood vessel growth and maintenance of vessel wall integrity.

Conclusion— These data illustrate that impaired ischemia-induced neovascularization in type 2 diabetes is associated with the dysregulation of a complex angiogenesis-regulatory network.

Angiogenic repair of ischemic hindlimbs was impaired in diabetic Leprdb/db and WT mice as evaluated by laser Doppler measurements. cDNA expression profiles were created from adductor muscle of Leprdb/db and WT mice before and after hindlimb ischemia illustrating the dysregulation of a complex angiogenesis-regulatory network in diabetic mice.


Key Words: diabetes • ischemia • angiogenesis • microarrays




This article has been cited by other articles:


Home page
Diabetes CareHome page
J. Siebert, M. Reiwer-Gostomska, Z. Babinska, J. Mysliwska, A. Mysliwski, E. Skopinska-Rozewska, E. Sommer, and P. Skopinski
Low Serum Angiogenin Concentrations in Patients With Type 2 Diabetes
Diabetes Care, December 1, 2007; 30(12): 3086 - 3087.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Ji, F. Mac Gabhann, and A. S. Popel
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Kivela, M. Silvennoinen, M. Lehti, H. Kainulainen, and V. Vihko
Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2573 - H2579.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
S. M. Vartanian and R. Sarkar
Therapeutic Angiogenesis
Vascular and Endovascular Surgery, July 1, 2007; 41(3): 173 - 185.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Miller, L. E. Norton, M. P. Murphy, M. C. Dalsing, and J. L. Unthank
The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2523 - H2531.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Li, S. Hazarika, D. Xie, A. M. Pippen, C. D. Kontos, and B. H. Annex
In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia
Diabetes, March 1, 2007; 56(3): 656 - 665.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Yakar, N. P. Nunez, P. Pennisi, P. Brodt, H. Sun, L. Fallavollita, H. Zhao, L. Scavo, R. Novosyadlyy, N. Kurshan, et al.
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Endocrinology, December 1, 2006; 147(12): 5826 - 5834.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Schiekofer, I. Shiojima, K. Sato, G. Galasso, Y. Oshima, and K. Walsh
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure
Physiol Genomics, October 11, 2006; 27(2): 156 - 170.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. Kivela, M. Silvennoinen, A.-M. Touvra, T. M. Lehti, H. Kainulainen, and V. Vihko
Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle
FASEB J, July 1, 2006; 20(9): 1570 - 1572.
[Abstract] [Full Text] [PDF]